Cartridge Technologies acquired by CenterGate Capital from Broadtree Partners

TAGS

Broadtree Partners, a recognized lower-middle market private equity firm, confirmed the acquisition of its portfolio entity, Cartridge Technologies, LLC (CTI), by CenterGate Capital, a reputed middle-market private equity enterprise. The specifics of this deal, facilitated by DC Advisory (DCA) representing CTI, remain undisclosed.

Broadtree Partners Reflects on CTI’s Journey

Brad Batten, the Managing Partner at Broadtree, stated, “We are proud to have collaborated with the CTI founders and team, marking a triumphant phase in CTI’s chronicle. Colin Murphy’s adept leadership coupled with CTI’s robust team has perpetuated the founder’s legacy, positioning the business for remarkable accomplishments.”

See also  Inszone Insurance Services acquires CBIA Insurance Agency

Diving Deep into CTI’s Legacy and Performance

Founded in 1990, Cartridge Technologies has made its mark as an esteemed contractor for the Federal Government. With a vast clientele spanning over 200 distinctive entities across all U.S. states, Cartridge Technologies boasts over three decades of unparalleled prowess. The firm aids federal agencies in curating, introducing, and supervising supremely secure print environments through its cutting-edge print hardware and software tools.

See also  Gland Pharma gets FDA tentative approval for Sugammadex Injection

Emphasizing its dedication to the mission, CTI’s strategy ensures proficient MPS solutions delivery catering to clients with strict and high-security mandates. The company’s alliance with Broadtree manifested in a revenue hike surpassing 2.5 times, a 35% headcount augmentation, and an 80% upswing in managed devices.

Cartridge Technologies CEO, Colin Murphy, expressed, “It fills me with pride to acknowledge CTI team’s achievements. We’ve emerged as a top-tier managed print services provider for the federal government. Our forthcoming growth chapter, in collaboration with CenterGate, seems promising.”

See also  Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases

Concluding the formalities, Holland & Knight served as the legal counsel to Broadtree and Cartridge Technologies.

CATEGORIES
TAGS
Share This